AB Science S.A.

€0.51As of Sun 8 Nov 2026, 12:00 UTC
EPA:ABHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (25.86%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.24
PE TTM —
TSR TTM (58.66%)
Mkt cap €40.49M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.553
9.26%
(89.81%)
Hold 6|9|4|5|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
(1.79%)
3.74%
19.85%
27.00%
Revenue€M
3.644
3.551
3.543
3.683
7.98%
8.11%
4.03%
4.86%
Peers (US$45.46M)
Cap (US$)
PE
388.0M
13.19x
85.49M
—
40.99M
—
Capital
TTM
5Y
10Y
Leveragex
2.068
(0.205)
(0.188)
EBIT/Intx
10.36
0.258
0.285
Own earn%
648.82
20.08
16.48
Sh yield%
44.03
56.84
54.10
Owners
Insiders/Inst%
10.57
81.38
Short interest%
2.39
SBC / revenue%
3.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
8–14
$1 testx
—
Incr. ROIC%
4